Our Services
Medical Information
Helpful Resources
Published on: 9/22/2026
Terbinafine is an antifungal medicine used to treat fungal infections of the skin, scalp, and nails, including athlete's foot, jock itch, ringworm, and toenail or fingernail fungus. Treatment length varies by location: topical creams and gels are often used for 1 to 4 weeks, while oral tablets are typically taken for 2 to 6 weeks for skin and scalp infections, about 6 weeks for fingernail fungus, and around 12 weeks for toenail fungus. Because nails grow slowly, visible improvement can take several more months after the medication is finished, and factors like liver health, other medications, and infection severity can change the plan, so review the complete answer below before starting or stopping treatment.
If you are not certain whether your rash, itching, or discolored nail is actually fungal, treating it with the wrong product can waste weeks and delay relief, since eczema, psoriasis, and bacterial infections can look similar. Take a free, instant online symptom check to better understand what may be causing your symptoms and what sensible next steps, including when to see a clinician, look like for you.
Last reviewed for medical accuracy: 09/22/2026
Terbinafine is a prescription antifungal medication available in topical (cream, gel, spray) and oral (tablet) forms. It’s primarily used to treat skin and nail infections caused by fungi. Understanding what terbinafine treats and how long you’ll need it can help you set realistic expectations and get the best results.
Terbinafine belongs to a class of drugs called allylamines. It works by:
Applied directly to the affected area, topical terbinafine treats mild to moderate skin infections, including:
Taken as a tablet, oral terbinafine reaches deeper skin layers and the nail bed. It’s most often used for:
Treatment duration depends on the type and location of the infection, and whether you’re using topical or oral therapy.
Even if symptoms improve sooner, finish the full course to reduce the risk of recurrence.
While many people tolerate terbinafine well, it can cause side effects. Most are mild and go away over time. If you notice anything concerning, talk to your doctor.
Common (topical and oral):
Less common (oral form):
Rare but serious (oral form):
Stop therapy and seek medical help if you experience:
Most fungal infections respond well to terbinafine. However, see a doctor if you notice:
For a quick check of your symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Terbinafine is a targeted, effective option for many common fungal infections. Treatment length varies by condition and formulation:
Always complete the full course, even if you feel better sooner. And remember to speak to a doctor if you experience serious symptoms, have underlying health conditions or are taking other medications. Your healthcare provider can help ensure terbinafine is right for you and monitor for any potential complications.
If you have any concerns about your treatment or notice severe symptoms, speak to a doctor promptly—especially if something could be life threatening or serious.
(References)
* Moossavi M, Bagheri B, Scher RK. Systemic antifungal therapy. Dermatol Clin. 2001 Jan;19(1):35-52. doi: 10.1016/s0733-8635(05)70228-x. PMID: 11155585.
* Reinel D. [Onychomycosis]. Hautarzt. 2004 Feb;55(2):143-9. doi: 10.1007/s00105-003-0680-5. PMID: 14968324.
* Seebacher C, Abeck D, Brasch J, Cornely O, Daeschlein G, Effendy I, Ginter-Hanselmayer G, Haake N, Hamm G, Hipler UC, Hof H, Korting HC, Kramer A, Mayser P, Ruhnke M, Schlacke KH, Tietz HJ. Tinea capitis. J Dtsch Dermatol Ges. 2006 Dec;4(12):1085-91. doi: 10.1111/j.1610-0387.2006.06133.x. PMID: 17176418.
* Kumari R, Timshina DK, Thappa DM. Drug hypersensitivity syndrome. Indian J Dermatol Venereol Leprol. 2011 Jan-Feb;77(1):7-15. doi: 10.4103/0378-6323.74964. PMID: 21220873.
* Maxfield L, Preuss CV, Bermudez R. Terbinafine. 2023 Jan. PMID: 31424802.
* Yao L, Song Y, Zhou JF, Cui Y, Li SS. Epidemiological and clinical comparisons of paediatric and adult sporotrichosis in Jilin Province, China. Mycoses. 2020 Mar;63(3):308-313. doi: 10.1111/myc.13045. Epub 2019 Dec 23. PMID: 31829465.
* Frazier WT, Santiago-Delgado ZM, Stupka KC 2nd. Onychomycosis: Rapid Evidence Review. Am Fam Physician. 2021 Oct 1;104(4):359-367. PMID: 34652111.
* Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Tinea versicolor: an updated review. Drugs Context. 2022;11. doi: 10.7573/dic.2022-9-2. Epub 2022 Nov 14. PMID: 36452877; PMCID: PMC9677953.
* Khodadadi RB, Yetmar ZA, Montagnon CM, Johnson EF, Abu Saleh OM. Majocchi's granuloma-A multicenter retrospective cohort study. JAAD Int. 2023 Dec;13:104-111. doi: 10.1016/j.jdin.2023.08.010. Epub 2023 Aug 23. PMID: 37744668; PMCID: PMC10517273.
* Gupta AK, Wang T, Mann A, Polla Ravi S, Talukder M, Lincoln SA, Foreman HC, Kaplan B, Galili E, Piguet V, Shemer A, Bakotic WL. Antifungal resistance in dermatophytes - review of the epidemiology, diagnostic challenges and treatment strategies for managing Trichophyton indotineae infections. Expert Rev Anti Infect Ther. 2024 Sep;22(9):739-751. doi: 10.1080/14787210.2024.2390629. Epub 2024 Aug 18. PMID: 39114868.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.